MilesDavidHagnerMD

Critical Care Medicine, Infectious Disease, Interstitial Lung Diseases, Restrictive Lung Disease

Pulmonary and Critical Care Fellow

Dr. Hagner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
200 Hawkins Dr
Iowa City, IA 52242
Phone+1 319-356-4419

Fax+1 319-353-6406

University of Iowa Hospitals and ClinicsFellowship, Pulmonary Disease and Critical Care Medicine, 2020 - 2023
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 2017 - 2020
The University of Toledo College of MedicineClass of 2017
Miami UniversityBS, Microbiology, Magna Cum Laude, 2009 - 2013

PubMed

Cannonball Pulmonary Lesions.
Elizabeth Wittrock, Miles D Hagner
The New England Journal of Medicine. 2024-09-05
Colourful complication of chronic minocycline use.
Mark Frommelt, Miles Hagner, Thomas J Gross
BMJ Case Reports. 2024-07-10
2 citations
Serum Vascular Endothelial Growth Factor-C as a Marker of Therapeutic Response to Sirolimus in Lymphangioleiomyomatosis.
Nishant Gupta, Miles Hagner, Huixing Wu, Lisa R. Young, Anushka Palipana
Annals of the American Thoracic Society. 2021-01-01

Journal Articles

Serum Vascular Endothelial Growth Factor-C as a Marker of Therapeutic Response to Sirolimus in Lymphangioleiomyomatosis
Nishant Gupta, Miles Hagner, Huixing Wu, Lisa R Young, Anushka Palipana, Rhonda D Szczesniak, and Francis X. McCormack, Annals of the American Thoracic Society